Minai O - Search Results

1

The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertension.

Tharwani A, Minai O, Rao Y, Kim H, Heresi GA. Tharwani A, et al. Among authors: minai o. Respir Med. 2024 Dec 22;237:107919. doi: 10.1016/j.rmed.2024.107919. Online ahead of print. Respir Med. 2024. PMID: 39716656

2

Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy.

Heresi GA, Minai OA. Heresi GA, et al. Respir Med. 2007 Oct;101(10):2099-107. doi: 10.1016/j.rmed.2007.05.020. Epub 2007 Jul 6. Respir Med. 2007. PMID: 17618103 Free article.

3

Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.

Diaz-Guzman E, Heresi GA, Dweik RA, Minai OA. Diaz-Guzman E, et al. Respir Med. 2008 May;102(5):681-9. doi: 10.1016/j.rmed.2007.12.020. Epub 2008 Feb 14. Respir Med. 2008. PMID: 18280130 Free article.

4

Causes and circumstances of death in pulmonary arterial hypertension.

Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, Dweik RA. Tonelli AR, et al. Am J Respir Crit Care Med. 2013 Aug 1;188(3):365-9. doi: 10.1164/rccm.201209-1640OC. Am J Respir Crit Care Med. 2013. PMID: 23600433 Free PMC article.

5

Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure.

Heresi GA, Minai OA, Tonelli AR, Hammel JP, Farha S, Parambil JG, Dweik RA. Heresi GA, et al. Pulm Circ. 2013 Dec;3(4):916-25. doi: 10.1086/674756. Pulm Circ. 2013. PMID: 25006408 Free PMC article.

6

Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.

Rose JA, Cleveland JM, Rao Y, Minai OA, Tonelli AR. Rose JA, et al. Among authors: minai oa. Chest. 2016 May;149(5):1234-44. doi: 10.1016/j.chest.2015.11.008. Epub 2016 Jan 13. Chest. 2016. PMID: 26836910 Free PMC article.

7

Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.

Ascha M, Zhou X, Rao Y, Minai OA, Tonelli AR. Ascha M, et al. Among authors: minai oa. Cardiovasc Ther. 2017 Oct;35(5):10.1111/1755-5922.12281. doi: 10.1111/1755-5922.12281. Cardiovasc Ther. 2017. PMID: 28643420 Free PMC article.

8

Bosentan in systemic sclerosis.

Heresi GA, Minai OA. Heresi GA, et al. Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138. Drugs Today (Barc). 2008. PMID: 18596996 Review.

9

Presence and outcomes of kidney disease in patients with pulmonary hypertension.

Navaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M, Dweik RA. Navaneethan SD, et al. Clin J Am Soc Nephrol. 2014 May;9(5):855-63. doi: 10.2215/CJN.10191013. Epub 2014 Feb 27. Clin J Am Soc Nephrol. 2014. PMID: 24578332 Free PMC article.

10

Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension.

Minai OA, Gudavalli R, Mummadi S, Liu X, McCarthy K, Dweik RA. Minai OA, et al. Am J Respir Crit Care Med. 2012 Feb 15;185(4):400-8. doi: 10.1164/rccm.201105-0848OC. Epub 2011 Nov 22. Am J Respir Crit Care Med. 2012. PMID: 22108205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters